Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901208 · ClinicalTrials.gov registry record · NA
Acute Effects of Vaping Nicotine on Cognition in Young Adults
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04901208: Completed NA study, sponsored by Yale University.
NCT04901208 is a NA study that has completed, run by Yale University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04901208, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To examine reward processing and cognitive control both with and without the influence of vaporized nicotine in young adults with no history of cigarette use using EEG and fMRI. The goal is to determine whether acute nicotine administration using a Juul device would impact functional correlates of reward and inhibitory control in people who commonly use juul devices.
Primary Outcome
FMRI measures of brain activation in response to reward
Interventions
- DRUG Nicotine pod
- DRUG Placebo pod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-04-05 |
| Est. Completion | 2022-08-17 |
| Phase | NA |
What the finished NCT04901208 record still lists
NCT04901208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Nicotine pod is the first listed.
NCT04901208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04901208 about?
NCT04901208 is a clinical study titled "Acute Effects of Vaping Nicotine on Cognition in Young Adults". To examine reward processing and cognitive control both with and without the influence of vaporized nicotine in young adults with no history of cigarette use using EEG and fMRI. The goal is to determine whether acute nicotine administration using a Juul device would impact functional correlates of r...
What is the current status of trial NCT04901208?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-04-05. Estimated completion is 2022-08-17.
What interventions are being tested in trial NCT04901208?
The interventions under investigation include: Nicotine pod (DRUG), Placebo pod (DRUG).
Who is sponsoring clinical trial NCT04901208?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04901208's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI